scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JOCN.2007.08.013 |
P698 | PubMed publication ID | 18617409 |
P2093 | author name string | Carlos Singer | |
Spiridon Papapetropoulos | |||
Andreas A Argyriou | |||
Elizabeth Chroni | |||
Lina Shehadeh | |||
Nanette Bishopric | |||
Nikhil Adi | |||
P433 | issue | 9 | |
P1104 | number of pages | 4 | |
P304 | page(s) | 1027-1030 | |
P577 | publication date | 2008-07-09 | |
P1433 | published in | Journal of Clinical Neuroscience | Q6294963 |
P1476 | title | Is the G2019S LRRK2 mutation common in all southern European populations? | |
P478 | volume | 15 |
Q36188579 | Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations |
Q46724331 | Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson’s disease in a Han-Chinese population in south-eastern China |
Q44696634 | Genetic assessment of familial and early-onset Parkinson's disease in a Greek population |
Q54786905 | LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity. |
Q60047792 | Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease |
Q38738200 | Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease. |
Q37597933 | The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews |
Q52374337 | The Role of LRRK2 in Neurodegeneration of Parkinson Disease |
Q34513714 | The genetic background of Parkinson's disease: current progress and future prospects |
Search more.